|
1
|
Friedman SL: Mechanisms of hepatic
fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friedman SL: Molecular mechanisms of
hepatic fibrosis and principles of therapy. J Gastroenterol.
32:424–430. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li D and Friedman SL: Liver fibrogenesis
and the role of hepatic stellate cells: New insights and prospects
for therapy. J Gastroenterol Hepatol. 14:618–633. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bissell DM, Roulot D and George J:
Transforming growth factor beta and the liver. Hepatology.
34:859–867. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Attisano L and Wrana JL: Signal
transduction by the TGF-beta superfamily. Science. 296:1646–1647.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Blahna MT and Hata A: Smad-mediated
regulation of microRNA biosynthesis. FEBS Lett. 586:1906–1912.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang XW, Heegaard NH and Orum H: MicroRNAs
in liver disease. Gastroenterology. 142:1431–1443. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu F, Guo Y, Chen B, Dong P and Zheng J:
MicroRNA-17-5p activates hepatic stellate cells through targeting
of Smad7. Lab Invest. 95:781–789. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ahn SM, Cha JY, Kim J, Kim D, Trang HT,
Kim YM, Cho YH, Park D and Hong S: Smad3 regulates E-cadherin via
miRNA-200 pathway. Oncogene. 31:3051–3059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhong X, Chung AC, Chen HY, Meng XM and
Lan HY: Smad3-mediated upregulation of miR-21 promotes renal
fibrosis. J Am Soc Nephrol. 22:1668–1681. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang F, Yang Z, Cao M, Xu Y, Li J, Chen
X, Gao Z, Xin J, Zhou S, Zhou Z, et al: MiR-203 suppresses tumor
growth and invasion and down-regulates MiR-21 expression through
repressing Ran in esophageal cancer. Cancer Lett. 342:121–129.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang C, Wang X, Liang H, Wang T, Yan X,
Cao M, Wang N, Zhang S, Zen K, Zhang C and Chen X: miR-203 inhibits
cell proliferation and migration of lung cancer cells by targeting
PKCα. PLoS One. 8:e739852013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Ren F, Rong M, Luo Y, Dang Y and
Chen G: Association between underexpression of microrna-203 and
clinicopathological significance in hepatocellular carcinoma
tissues. Cancer Cell Int. 15:622015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song Y, Zhan L, Yu M, Huang C, Meng X, Ma
T, Zhang L and Li J: TRPV4 channel inhibits TGF-β1-induced
proliferation of hepatic stellate cells. PLoS One. 9:e1011792014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vogel S, Piantedosi R, Frank J, Lalazar A,
Rockey DC, Friedman SL and Blaner WS: An immortalized rat liver
stellate cell line (HSC-T6): A new cell model for the study of
retinoid metabolism in vitro. J Lipid Res. 41:882–893.
2000.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen K and Rajewsky N: Natural selection
on human microRNA binding sites inferred from SNP data. Nat Genet.
38:1452–1456. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Betel D, Koppal A, Agius P, Sander C and
Leslie C: Comprehensive modeling of microRNA targets predicts
functional non-conserved and non-canonical sites. Genome Biol.
11:R902010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gressner AM: Cytokines and cellular
crosstalk involved in the activation of fat-storing cells. J
Hepatol. 22 Suppl 2:S28–S36. 1995.
|
|
24
|
Nouchi T, Tanaka Y, Tsukada T, Sato C and
Marumo F: Appearance of alpha-smooth-muscle-actin-positive cells in
hepatic fibrosis. Liver. 11:100–105. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wells RG: Fibrogenesis. V. TGF-beta
signaling pathways. Am J Physiol Gastrointest Liver Physiol.
279:G845–G850. 2000.PubMed/NCBI
|
|
26
|
Friedman SL: Evolving challenges in
hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 7:425–436. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Safadi R and Friedman SL: Hepatic
fibrosis-role of hepatic stellate cell activation. Med Gen Med.
4:272002.
|
|
28
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ghiassi-Nejad Z and Friedman SL: Advances
in antifibrotic therapy. Expert Rev Gastroenterol Hepatol.
2:803–816. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Borkham-Kamphorst E, van Roeyen CR,
Ostendorf T, Floege J, Gressner AM and Weiskirchen R:
Pro-fibrogenic potential of PDGF-D in liver fibrosis. J Hepatol.
46:1064–1074. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Paradis V, Dargere D, Vidaud M, de
Gouville AC, Huet S, Martinez V, Gauthier JM, Ba N, Sobesky R,
Ratziu V and Bedossa P: Expression of connective tissue growth
factor in experimental rat and human liver fibrosis. Hepatology.
30:968–976. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rockey DC, Fouassier L, Chung JJ, Carayon
A, Vallee P, Rey C and Housset C: Cellular localization of
endothelin-1 and increased production in liver injury in the rat:
Potential for autocrine and paracrine effects on stellate cells.
Hepatology. 27:472–480. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shi Y and Massagué J: Mechanisms of
TGF-beta signaling from cell membrane to the nucleus. Cell.
113:685–700. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu D, He X, Duan Y, Chen J, Wang J, Sun
X, Qian H, Feng J, Sun W, Xu F and Zhang L: Expression of
microRNA-454 in TGF-β1-stimulated hepatic stellate cells and in
mouse livers infected with Schistosoma japonicum. Parasit Vectors.
7:1482014. View Article : Google Scholar : PubMed/NCBI
|
